Other variables including estrogen receptor (ER), progesterone receptor (PR), and epidermal growth factor receptor-2 (HER2) expression vary widely among breast cancer patients and thus are routinely assessed as a component of standard care for determining the most effective treatment. Here, PGR is linked to breast cancer.